BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23044956)

  • 1. Central serous chorioretinopathy in myopic patients.
    Yzer S; Fung AT; Barbazetto I; Yannuzzi LA; Freund KB
    Arch Ophthalmol; 2012 Oct; 130(10):1339-40. PubMed ID: 23044956
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of three-dimensional optical coherence tomography and fundus photochromy in correlating the fluorescein leaking sites of acute central serous chorioretinopathy.
    Wang GH; Zhang J; Zhang D; Lv FL; Wang LX
    Med Princ Pract; 2011; 20(3):283-6. PubMed ID: 21455001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central serous chorioretinopathy in young adults.
    Pryds A; Larsen M; Barbazetto I; Yannuzzi L
    Acta Ophthalmol; 2012 Aug; 90(5):e404-5. PubMed ID: 23043628
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral central serous retinopathy following laser in situ keratomileusis for myopia.
    Peponis VG; Chalkiadakis SE; Nikas SD; Makris NK; Ladas ID; Karagiannis DA
    J Cataract Refract Surg; 2011 Apr; 37(4):778-80. PubMed ID: 21420605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse multiple sclerosis and chronic central serous chorioretinopathy: pitfall not to ignore.
    Milazzo S; Drimbea A; Betermiez P; Al Fayez S; Bremond-Gignac D
    Pract Neurol; 2013 Jun; 13(3):200-3. PubMed ID: 23487813
    [No Abstract]   [Full Text] [Related]  

  • 6. Myopic foveal detachment associated with pachychoroid characteristics.
    Shin YK; Han SH; Kang SW; Kim SJ; Kim AY
    BMC Ophthalmol; 2021 Jul; 21(1):288. PubMed ID: 34320927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab injection for central serous chorioretinopathy.
    Lim SJ; Roh MI; Kwon OW
    Retina; 2010 Jan; 30(1):100-6. PubMed ID: 20010322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy.
    Yalcinbayir O; Gelisken O; Akova-Budak B; Ozkaya G; Gorkem Cevik S; Yucel AA
    Retina; 2014 Apr; 34(4):705-12. PubMed ID: 24100708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical factors related to visual outcome in central serous chorioretinopathy.
    Aggio FB; Roisman L; Melo GB; Lavinsky D; Cardillo JA; Farah ME
    Retina; 2010; 30(7):1128-34. PubMed ID: 20616688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy.
    Maruko I; Iida T; Ojima A; Sekiryu T
    Retina; 2011 Apr; 31(4):759-65. PubMed ID: 21052035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photopigments in central serous chorioretinopathy.
    Ojima A; Iida T; Sekiryu T; Maruko I; Sugano Y
    Am J Ophthalmol; 2011 Jun; 151(6):940-952.e1. PubMed ID: 21457927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
    Imamura Y; Fujiwara T; Spaide RF
    Ophthalmology; 2011 Apr; 118(4):700-5. PubMed ID: 21055816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.
    Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F
    Retina; 2013; 33(10):2096-102. PubMed ID: 23719402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal microstructural abnormalities in central serous chorioretinopathy and polypoidal choroidal vasculopathy.
    Ooto S; Tsujikawa A; Mori S; Tamura H; Yamashiro K; Otani A; Yoshimura N
    Retina; 2011 Mar; 31(3):527-34. PubMed ID: 20890237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choroidal thickness in central serous chorioretinopathy.
    Kuroda S; Ikuno Y; Yasuno Y; Nakai K; Usui S; Sawa M; Tsujikawa M; Gomi F; Nishida K
    Retina; 2013 Feb; 33(2):302-8. PubMed ID: 23064424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective retina therapy for acute central serous chorioretinopathy.
    Klatt C; Saeger M; Oppermann T; Pörksen E; Treumer F; Hillenkamp J; Fritzer E; Brinkmann R; Birngruber R; Roider J
    Br J Ophthalmol; 2011 Jan; 95(1):83-8. PubMed ID: 20554506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab injection for central serous chorioretinopathy.
    Nowroozzadeh MH
    Retina; 2010 Sep; 30(8):1322-3; author reply 1323. PubMed ID: 20827148
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravitreal bevacizumab injection for central serous chorioretinopathy.
    Chhablani JK; Narayanan R
    Retina; 2010 Sep; 30(8):1323-24; author reply 1324. PubMed ID: 20661171
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual cycle suppression via patching in central serous chorioretinopathy.
    Earl JB; Lee CS; Yom V; Van Stavern GP; Abuattieh M; Chin-Yee D; Rao PK; Apte RS
    Ophthalmology; 2014 Dec; 121(12):2502-4.e1. PubMed ID: 25109933
    [No Abstract]   [Full Text] [Related]  

  • 20. Multimodal Imaging in Central Serous Chorioretinopathy.
    Gattoussi S; Freund KB
    Ophthalmology; 2017 Sep; 124(9):1331. PubMed ID: 28823348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.